Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

被引：10
|
作者：
Pan, Kathy [1 ]
Bosserman, Linda Diana [2 ]
Chlebowski, Rowan T. [1 ]
机构：
[1] Los Angeles Biomed Res Inst, 1124 W Carson St,Bldg N-16, Torrance, CA 90502 USA
[2] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 11期
关键词：
WOMEN; TAMOXIFEN; EFFICACY;
D O I：
10.1200/JCO.18.01360
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：858 / +
页数：5
相关论文
共 50 条
  • [31] Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer
    Howell, A.
    [J]. BREAST CANCER RESEARCH, 2007, 9 (01)
  • [32] Controversies in the management of patients with breast cancer: Adjuvant endocrine therapy in premenopausal women
    Parton, Marina
    Smith, Ian E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) : 745 - 752
  • [33] Social Characteristics and Adherence to Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer
    Schmidt, Julie A.
    Woolpert, Kirsten M.
    Hjorth, Cathrine F.
    Farkas, Dora K.
    Ejlertsen, Bent
    Cronin-Fenton, Deirdre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (28)
  • [34] Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer
    Mathew, Aju
    Davidson, Nancy E.
    [J]. BREAST, 2015, 24 : S120 - S125
  • [35] Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer
    A Howell
    [J]. Breast Cancer Research, 9
  • [36] Addition of ovarian function suppression to endocrine therapy in premenopausal women with early breast cancer: A meta-analysis
    Chlebowski, R.
    Pan, K.
    Col, N. F.
    [J]. CANCER RESEARCH, 2017, 77
  • [37] Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China
    Zhong, Xiaorong
    Chen, Ping
    He, Ping
    Wu, Yanqi
    Suo, Jiaojiao
    Zhu, Kunrui
    Yan, Xi
    Tian, Tinglun
    Yang, Qing
    Luo, Ting
    [J]. CLINICAL BREAST CANCER, 2024, 24 (02) : e41 - e50
  • [38] Ovarian ablation or suppression in premenopausal early breast cancer: Results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial
    Bliss, J. M.
    Johnson, L.
    Lawrence, D.
    Peto, J.
    Price, D.
    Yarnold, J.
    Barrett-Lee, P.
    Brunt, A. M.
    Dodwell, D.
    Earl, H.
    Fernando, I.
    Foster, L.
    George, W. D.
    Harnett, A. M.
    Perren, T.
    Poole, C.
    Raina, V.
    Robinson, A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07) : 516 - 525
  • [39] Adjuvant Endocrine Treatment in Premenopausal Early Breast Cancer
    Orlando, L.
    Fedele, P.
    Cinefra, M.
    Sponziello, F.
    Calvani, N.
    Chetri, M. C.
    Rizzo, P.
    D'Amico, M.
    Schiavone, P.
    Portaluri, M.
    Criscuolo, M.
    Burlizzi, S.
    Cinieri, S.
    [J]. ONCOLOGY, 2009, 77 : 9 - 13
  • [40] Adjuvant Ovarian Function Suppression in Premenopausal Hormone Receptor-Positive Breast Cancer
    Basmadjian, Robert B.
    Lupichuk, Sasha
    Xu, Yuan
    Quan, May Lynn
    Cheung, Winson Y.
    Brenner, Darren R.
    [J]. JAMA NETWORK OPEN, 2024, 7 (03) : E242082
12345